Cedars-sinai medical center:1110239 [19-029097]. Tissue source site (TSS)for NCI's clinical proteomic tumor analysis consortium (CPTAC) cases eligible for payment 4.

Ended Awarded Last action

Contract number
75N91019F00129
Awardee
Awarding agency
Obligated
$0

Award facts

Opportunity
Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
West Hollywood, CA 90048, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · Tissue source site (TSS)for NCI's clinical proteomic tumor analysis consortium (CPTAC) cases -$1,229
Original award $1,229

Quick answers

Who was awarded contract 75N91019F00129?

75N91019F00129 was awarded to Cedars-Sinai Medical Center by National Cancer Institute (National Institutes of Health) on July 15, 2019.

How much is contract 75N91019F00129 worth?

The government has obligated $0 on 75N91019F00129.

Is contract 75N91019F00129 an order under another contract?

Yes. 75N91019F00129 is a delivery order under HHSN261201600008I, an indefinite delivery contract, on Tissue Source Site for Tumor Analysis.

Was contract 75N91019F00129 competed?

The extent of competition for 75N91019F00129 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login